Global Malignant Neoplasms Mortality by Country

In 2024, malignant neoplasms mortality rates varied significantly between countries. The highest female mortality rates were in Hungary, Slovenia, and Croatia, with Hungary topping the list at 295.6 deaths per hundred thousand women. Notably, Hungary experienced a marginal increase of 0.15% compared to the previous year. In contrast, significant decreases were observed in Luxembourg (-2.27%) and Argentina (-1.26%) over the last year. Countries such as Greece, Portugal, and South Korea saw the highest year-on-year increases at 1.19%, 1.38%, and 1.28%, respectively. Latin American countries like Peru showed a dramatic year-on-year increase of 3.21% in mortality rates.

Overall, many European countries, despite having high mortality rates, are seeing mixed trends, with some reductions as seen in the UK and Belgium, while others like Latvia and Lithuania are experiencing increases. The United States and Canada have modest but declining trends, whereas, in many South American and African countries, mortality rates are notably lower but increasing. These patterns may be linked to healthcare infrastructure, lifestyle changes, and possibly epidemiological transitions.

Looking ahead, the global health community should focus on observing trends in countries with rapidly changing rates, such as Peru, South Korea, and Greece. Monitoring advancements in cancer treatment technologies, public health policies, and the broader socio-economic factors will be crucial for understanding future shifts in malignant neoplasms mortality rates.